Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Natco Pharma Ltd
Long-Term Debt Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Long-Term Debt
â‚ą53m
CAGR 3-Years
81%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Debt
â‚ą6B
CAGR 3-Years
-2%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Debt
â‚ą2.2B
CAGR 3-Years
-28%
CAGR 5-Years
-41%
CAGR 10-Years
-3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Debt
â‚ą3.7B
CAGR 3-Years
-17%
CAGR 5-Years
-30%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Debt
â‚ą14.7B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Debt
â‚ą325.8m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Long-Term Debt?
Long-Term Debt
53m INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Long-Term Debt amounts to 53m INR.

What is Natco Pharma Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
-25%

Over the last year, the Long-Term Debt growth was 382%. The average annual Long-Term Debt growth rates for Natco Pharma Ltd have been 81% over the past three years , and -25% over the past ten years .

Back to Top